Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Whitehouse

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Family Practice|November 11, 2020
Which behavioral health screening tool should you use-and when?Rebecca Sewell, Elizabeth Cottrell, Karina Gutman, et al.
Drugs & Aging|November 24, 2022
Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trialGereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, et al.
Drugs & Aging|December 19, 2022
Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trialGereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, et al.
BMJ Open|February 10, 2024
A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care (nursing home) (ADEPT): protocol for a feasibility studyMonique S Boord, Peter Brown, Julian Soriano, et al.
Drug Safety|April 19, 2023
Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR TrialLisa M Kalisch Ellett, Gerel Dorj, Andre Q Andrade, et al.
BMJ Open|April 25, 2020
Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcomeRenly Lim, Luke Bereznicki, Megan Corlis, et al.
Age and Ageing|April 23, 2022
Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)Elizabeth E Roughead, Nicole L Pratt, Gaynor Parfitt, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Family Practice|November 11, 2020
Which behavioral health screening tool should you use-and when?Rebecca Sewell, Elizabeth Cottrell, Karina Gutman, et al.
Drugs & Aging|November 24, 2022
Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trialGereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, et al.
Drugs & Aging|December 19, 2022
Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trialGereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, et al.
BMJ Open|February 10, 2024
A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care (nursing home) (ADEPT): protocol for a feasibility studyMonique S Boord, Peter Brown, Julian Soriano, et al.
Drug Safety|April 19, 2023
Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR TrialLisa M Kalisch Ellett, Gerel Dorj, Andre Q Andrade, et al.
BMJ Open|April 25, 2020
Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcomeRenly Lim, Luke Bereznicki, Megan Corlis, et al.
Age and Ageing|April 23, 2022
Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)Elizabeth E Roughead, Nicole L Pratt, Gaynor Parfitt, et al.
Pageof 2